Ferring’s Zomacton

Zomacton was developed by Ferring Pharmaceuticals. It is available for sale worldwide. Zomacton is manufactured by Protein Secretion technology. In the U.S., the Food and Drug Administration (FDA — an agency that regulates the medicine market) has approved Zomacton for treatment of pediatric and adult GHD, and growth failure in females with Turner’s syndrome. Ferring’s Zomajet 2 Vision™ is a needle-less means of HGH injection.